| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 6,000 | ₹1,20,000 |
| HNI / NII | 2 | 12,000 | ₹2,40,000 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII / HNI (Total) | — | 8,52,000 (47.33%) | — | ₹170.40 Cr |
| Retail Investors | — | 8,52,000 (47.33%) | — | ₹170.40 Cr |
| Total ** | — | 18,00,000 (100.00%) | — | ₹3,600.00 Cr |
| Market Maker * | — | 96,000 (5.33%) | — | ₹1.92 Cr |
| Metric | 30-Sep-21 | 31-Mar-21 | 31-Mar-20 |
|---|---|---|---|
| Revenue | 272.54 | 27.43 | 34.56 |
| PAT | 12.63 | 0.74 | 1.40 |
| EBITDA | — | — | — |
| Net Worth | — | — | — |
| Total Assets | 588.68 | 47.13 | 27.26 |
| Reserves | — | — | — |
| Borrowings | — | — | — |
Incorporated in 1996, Achyut Healthcare Limited is engaged in the trading of Pharmaceutical Products. The company has business operations in both domestic and international markets in the countries namely UAE, Kenya, and Nigeria. The company is located in Ahmedabad, Gujarat.
The company involves in the trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products.
Competitive Strengths: